P3 Health Partners Inc. (PIII)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total operating revenue | 355,788 | 373,225 | 362,124 | 379,157 |
| Sales and marketing expense | 151 | 181 | 134 | 414 |
| Corporate, general and administrative expense | 23,295 | 24,999 | 27,219 | 26,610 |
| Depreciation and amortization | 21,083 | 21,052 | 21,673 | 21,693 |
| Premium deficiency reserve | -5,967 | -6,962 | 18,168 | -3,397 |
| Medical expense | 351,350 | 372,043 | 401,920 | 365,171 |
| Total operating expense | 389,912 | 411,313 | 469,114 | 410,491 |
| Operating loss | -34,124 | -38,088 | -106,990 | -31,334 |
| Other | 583 | 318 | 445 | 291 |
| Interest expense, net | -10,145 | -8,725 | -5,647 | -5,436 |
| Mark-to-market of stock warrants | -2,002 | -3,322 | -5,737 | -8,673 |
| Total other income (expense) | -7,560 | -5,085 | 535 | 3,528 |
| Loss before income taxes | -41,684 | -43,173 | -106,455 | -27,806 |
| Income tax provision | 1,981 | 1,073 | -3,605 | 968 |
| Net loss | -43,665 | -44,246 | -102,850 | -28,774 |
| Less net loss attributable to redeemable non-controlling interest | -23,303 | -23,766 | -56,338 | -16,754 |
| Net loss attributable to controlling interest | -20,362 | -20,480 | -46,512 | -12,020 |
| Basic (in dollars per share) | -6.23 | -6.28 | -0.29 | -0.09 |
| Basic (in shares) | 3,267,000 | 3,260,000 | 161,890,000 | 136,601,000 |
| Diluted (in dollars per share) | -6.23 | -6.28 | -0.31 | -0.15 |
| Diluted (in shares) | 3,267,000 | 3,260,000 | 164,701,000 | 141,083,000 |